Literature DB >> 12595759

Characterization and functionality of cell surface molecules on human mesenchymal stem cells.

Manas K Majumdar1, Michele Keane-Moore, Diana Buyaner, Wayne B Hardy, Mark A Moorman, Kevin R McIntosh, Joseph D Mosca.   

Abstract

We have characterized adhesion molecules on the surface of multipotential human mesenchymal stem cells (hMSCs) and identified molecules whose ligands are present on mature hematopoietic cells. Flow cytometric analysis of hMSCs identified the expression of integrins: alpha1, alpha2, alpha3, alpha5, alpha6, alphav, beta1, beta3, and beta4, in addition to ICAM-1, ICAM-2, VCAM-1, CD72, and LFA-3. Exposure of hMSCs to IL-1alpha, TNFalpha or IFNgamma up-modulated ICAM-1 surface expression, whereas only IFNgamma increased both HLA-class I and -class II molecules on the cell surface. Whole cell-binding assays between the hMSCs and hematopoietic cell lines showed that T lymphocytic lines bound hMSCs with higher affinity than lines of either B lymphocytes or those of myeloid lineage. Experiments using autologous T lymphocytes isolated from peripheral blood mononuclear cells showed that hMSCs exhibited increased affinity for activated T-lymphocytes compared to resting T cells by quantitative whole cell binding and rosetting assays. Flow cytometric analysis of rosetted cells demonstrated that both CD4+ and CD8+ cells bound to hMSCs. To determine the functional significance of these findings, we tested the ability of hMSCs to present antigen to T lymphocytes. hMSCs pulsed with tetanus toxoid stimulated proliferation and cytokine production (IL-4, IL-10, and IFNgamma) in a tetanus-toxoid-specific T cell line. Maximal cytokine production correlated with maximal antigen-dependent proliferation. These data demonstrate physiological outcome as a consequence of interactions between hMSCs and human hematopoietic lineage cells, suggesting a role for hMSCs in vivo to influence both hematopoietic and immune function(s). Copyright 2003 National Science Council, ROC and S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595759     DOI: 10.1007/bf02256058

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


  130 in total

1.  Homing of Mesenchymal Stem Cells.

Authors:  Reinhard Henschler; Erika Deak; Erhard Seifried
Journal:  Transfus Med Hemother       Date:  2008-07-21       Impact factor: 3.747

2.  The use of four-colour immunofluorescence techniques to identify mesenchymal stem cells.

Authors:  Matthias Schieker; Christoph Pautke; Katharina Reitz; Indradeo Hemraj; Peter Neth; Wolf Mutschler; Stefan Milz
Journal:  J Anat       Date:  2004-02       Impact factor: 2.610

Review 3.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

4.  Tailored integrin-extracellular matrix interactions to direct human mesenchymal stem cell differentiation.

Authors:  Jessica Ellen Frith; Richard James Mills; James Edward Hudson; Justin John Cooper-White
Journal:  Stem Cells Dev       Date:  2012-05-31       Impact factor: 3.272

Review 5.  Stem cell therapy for ischemic heart disease.

Authors:  Mohammad Nurulqadr Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

6.  Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art.

Authors:  Arianna Malgieri; Eugenia Kantzari; Maria Patrizia Patrizi; Stefano Gambardella
Journal:  Int J Clin Exp Med       Date:  2010-09-07

7.  A comprehensive study on optimization of proliferation and differentiation potency of bone marrow derived mesenchymal stem cells under prolonged culture condition.

Authors:  M Dhanasekaran; S Indumathi; R P Lissa; R Harikrishnan; J S Rajkumar; D Sudarsanam
Journal:  Cytotechnology       Date:  2012-06-23       Impact factor: 2.058

8.  Bone-marrow-derived mesenchymal stem cells as a target for cytomegalovirus infection: implications for hematopoiesis, self-renewal and differentiation potential.

Authors:  Sergey V Smirnov; Ryhor Harbacheuski; Anita Lewis-Antes; Hua Zhu; Pranela Rameshwar; Sergei V Kotenko
Journal:  Virology       Date:  2006-11-17       Impact factor: 3.616

9.  Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells.

Authors:  J Kim; Y Lee; H Kim; K J Hwang; H C Kwon; S K Kim; D J Cho; S G Kang; J You
Journal:  Cell Prolif       Date:  2007-02       Impact factor: 6.831

10.  Optimization strategies for electrospun silk fibroin tissue engineering scaffolds.

Authors:  Anne J Meinel; Kristopher E Kubow; Enrico Klotzsch; Marcos Garcia-Fuentes; Michael L Smith; Viola Vogel; Hans P Merkle; Lorenz Meinel
Journal:  Biomaterials       Date:  2009-02-23       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.